SOLVENTUM CORP (SOLV) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:SOLV - US83444M1018 - Common Stock
SOLV Key Statistics, Chart & Performance
The current stock price of SOLV is 81.59 USD. In the past month the price increased by 2.62%. In the past year, price increased by 22.09%.
SOLV Latest News, Press Relases and Analysis
SOLV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 20.04 | 16.45B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.31 | 11.31B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.58 | 5.20B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.06 | 4.37B | ||
| HAE | HAEMONETICS CORP/MASS | 16.71 | 3.75B | ||
| ICUI | ICU MEDICAL INC | 18.23 | 3.58B | ||
| XRAY | DENTSPLY SIRONA INC | 7.09 | 2.24B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.58 | 1.77B | ||
| NEOG | NEOGEN CORP | 24 | 1.56B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.25B | ||
| EMBC | EMBECTA CORP | 3.96 | 687.49M | ||
| BVS | BIOVENTUS INC - A | 12.69 | 619.87M |
Related stock screener links
About SOLV
Company Profile
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 22,000 full-time employees. The company went IPO on 2024-03-26. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
Company Info
SOLVENTUM CORP
C/O 3M Company, 3M Center, Building 275-6W-02
ST. PAUL MINNESOTA US
Employees: 22000
Phone: 16517331110
SOLVENTUM CORP / SOLV FAQ
Can you describe the business of SOLVENTUM CORP?
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 22,000 full-time employees. The company went IPO on 2024-03-26. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
What is the current price of SOLV stock?
The current stock price of SOLV is 81.59 USD. The price increased by 1.13% in the last trading session.
What is the dividend status of SOLVENTUM CORP?
SOLV does not pay a dividend.
What is the ChartMill rating of SOLVENTUM CORP stock?
SOLV has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is SOLVENTUM CORP (SOLV) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SOLV.
What is the employee count for SOLV stock?
SOLVENTUM CORP (SOLV) currently has 22000 employees.
What is the outstanding short interest for SOLVENTUM CORP?
The outstanding short interest for SOLVENTUM CORP (SOLV) is 2.5% of its float.
SOLV Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to SOLV. When comparing the yearly performance of all stocks, SOLV is one of the better performing stocks in the market, outperforming 80.69% of all stocks.
SOLV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SOLV. While SOLV is still in line with the averages on profitability rating, there are concerns on its financial health.
SOLV Financial Highlights
Over the last trailing twelve months SOLV reported a non-GAAP Earnings per Share(EPS) of 5.94. The EPS increased by 108.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.14% | ||
| ROA | 10.91% | ||
| ROE | 30.57% | ||
| Debt/Equity | 1.03 |
SOLV Forecast & Estimates
21 analysts have analysed SOLV and the average price target is 87.55 USD. This implies a price increase of 7.3% is expected in the next year compared to the current price of 81.59.
For the next year, analysts expect an EPS growth of -8.16% and a revenue growth 0.5% for SOLV